One year versus a shorter duration of adjuvant trastuzumab for HER2-positive early breast cancer: a systematic review and meta-analysis Alessandro InnoSandro BarniFausto Petrelli Review 13 October 2018 Pages: 247 - 254
A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients Hye Won HwangHera JungEun Yoon Cho Review 15 October 2018 Pages: 255 - 266
Surgical trends in breast cancer: a rise in novel operative treatment options over a 12 year analysis Michael M. JonczykJolie JeanAbhishek Chatterjee Review 25 October 2018 Pages: 267 - 274
Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy Fouzia GuestiniKatsuhiko OnoKeely May McNamara Preclinical study 10 October 2018 Pages: 275 - 288
Mucin 2 (MUC2) modulates the aggressiveness of breast cancer Anna AstashchankaThomas M. ShrokaBritta M. Jacobsen Preclinical study 13 October 2018 Pages: 289 - 299
Breast conservation versus mastectomy in patients with T3 breast cancers (> 5 cm): an analysis of 37,268 patients from the National Cancer Database Anna M. MazorAlina M. MateoRichard J. Bleicher Preclinical study 20 October 2018 Pages: 301 - 311
High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study Martin P. NilssonErik D. NilssonNiklas Loman Clinical trial Open access 11 October 2018 Pages: 313 - 318
Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis Peter A. FaschingAndreas D. HartkopfHans-Christian Kolberg Clinical trial 15 October 2018 Pages: 319 - 328
Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis Xuexin HeJiali JiSai-Ching Jim Yeung Clinical trial 19 October 2018 Pages: 329 - 341
Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study Jean-Marc ClasseCecile LoaecL. Campion Clinical trial 20 October 2018 Pages: 343 - 352
A randomized trial of interpersonal psychotherapy, problem solving therapy, and supportive therapy for major depressive disorder in women with breast cancer Carlos BlancoJohn C. MarkowitzDawn L. Hershman Clinical trial 20 October 2018 Pages: 353 - 364
Machine learning for diagnostic ultrasound of triple-negative breast cancer Tong WuLaith R. SultanChandra M. Sehgal Clinical trial 20 October 2018 Pages: 365 - 373
Discrepancy in risk assessment of hormone receptor positive early-stage breast cancer patients using breast cancer index and recurrence score Piiha-Lotta JerevallJane BrockDennis C. Sgroi Clinical trial 22 October 2018 Pages: 375 - 383
Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea Jai Min RyuHee Jun ChoiKorean Hereditary Breast Cancer Study Group Clinical trial 22 October 2018 Pages: 385 - 395
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens Luc CabelMatthieu CartonFlorence Lerebours Clinical trial 24 October 2018 Pages: 397 - 406
Metronomic capecitabine combined with aromatase inhibitors for new chemoendocrine treatment of advanced breast cancer: a phase II clinical trial Jian-wei LiWen-jia ZuoGuang-yu Liu Clinical trial 25 October 2018 Pages: 407 - 415
The impact of gene expression profile testing on confidence in chemotherapy decisions and prognostic expectations Laura PanattoniTracy A. LieuScott D. Ramsey Epidemiology 10 October 2018 Pages: 417 - 427
Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice? André HennigsMelitta KöpkeJörg Heil Epidemiology 12 October 2018 Pages: 429 - 438
Improving the competency of medical students in clinical breast examination through a standardized simulation and multimedia-based curriculum Fernando A. AngaritaBenjamin PriceLilian Torregrossa Epidemiology 12 October 2018 Pages: 439 - 445
The influence of reconstruction choice and inclusion of radiation therapy on functional shoulder biomechanics in women undergoing mastectomy for breast cancer Joshua M. LeonardisBrian J. DiefenbachDavid B. Lipps Epidemiology 16 October 2018 Pages: 447 - 453
Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set Elizabeth Hope CainAshirbani SahaMaciej A. Mazurowski Epidemiology 16 October 2018 Pages: 455 - 463
Predictors of time to death after distant recurrence in breast cancer patients Victoria SopikPing SunSteven A. Narod Epidemiology 16 October 2018 Pages: 465 - 474
Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I–IIIB breast cancer receiving chemotherapy Maaike M. G. A. van den BergDieuwertje E. KokRenate M. Winkels Epidemiology Open access 23 October 2018 Pages: 475 - 481
Better pathological tumor characteristics might occur in recurrent metastatic breast cancer patients after 10-year metastatic free interval Kadri Altundag Letter to the Editor 15 October 2018 Pages: 483 - 483
Extranodular extension in sentinel lymph node-positive breast cancer might predict further initiation of completion axillary lymph node dissection Kadri Altundag Letter to the Editor 20 October 2018 Pages: 485 - 485
Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis Jiayu WangBinghe XuXuelian Chen Correction 23 November 2018 Pages: 487 - 487
